Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

PloS one·2026
Same author

Artificial intelligence in cardiovascular imaging 2025: insights from the National Societies Cardiology journals.

European heart journal·2026
Same author

Recurrent <i>Pasteurella multocida</i> urinary tract infection in a young adult with end-stage renal insufficiency: a case report.

ASM case reports·2026
Same author

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis.

Emerging microbes & infections·2026
Same author

What role does blood transfusion play in early infection risk for elderly patients with fractures of the proximal extremity of the femur treated surgically? A single center cohort study.

Orthopaedics & traumatology, surgery & research : OTSR·2026
Same author

History of Cardiology: ESC Congress 2025, Madrid.

European heart journal·2026

Related Experiment Video

Updated: Jun 26, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
10:04

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation

Published on: January 12, 2016

HIV-associated vascular diseases: structural and functional changes, clinical implications.

Jean-Jacques Monsuez1, Jean-Christophe Charniot, Lelia Escaut

  • 1AP-HP, Hôpital René Muret, Policlinique médicale, Université Paris, Sevran, France. jean-jacques.monsuez@rmb.aphp.fr

International Journal of Cardiology
|January 10, 2009
PubMed
Summary

The spectrum of HIV-associated vascular diseases has shifted from infections to premature atherosclerosis. Cardiovascular prevention is crucial for over half of HIV patients on modern antiretroviral therapy.

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Experiment Videos

Last Updated: Jun 26, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
10:04

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation

Published on: January 12, 2016

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Pathogenesis of Atherosclerosis

Background:

  • The landscape of HIV-associated vascular diseases has evolved significantly over two decades.
  • Initially dominated by infectious and inflammatory vasculitides, it now includes premature atherosclerosis and related conditions.

Purpose of the Study:

  • To analyze the shift in HIV-associated vascular diseases.
  • To highlight the increasing prevalence of cardiovascular manifestations in HIV-infected patients.
  • To underscore the need for integrated understanding of pathogenesis and cardiovascular risk management.

Main Methods:

  • Review of evolving clinical presentations of HIV-associated vascular diseases.
  • Analysis of contributing factors including viral infection, inflammation, and antiretroviral therapy side effects.
  • Assessment of cardiovascular risk and prevention strategies in HIV-infected populations.

Main Results:

  • HIV-associated vascular diseases now predominantly feature premature atherosclerosis, metabolic syndrome, dyslipidemia, and insulin resistance syndrome.
  • Cardiovascular manifestations affect over 10% of HIV-infected patients on effective antiviral regimens.
  • Cardiovascular prevention strategies are necessary for more than half of treated HIV patients.

Conclusions:

  • The complex interplay of HIV, inflammation, and antiretroviral therapy contributes to accelerated atherosclerosis.
  • Effective cardiovascular risk assessment and prevention are integral to modern antiretroviral therapy.
  • Improved prognosis and increased life expectancy in HIV patients necessitate ongoing cardiovascular monitoring and management.